Established in 1902, Iwata & Co., Ltd.’s main business is the manufacture and provision of an extensive range of chemicals to a wide variety of industries. The company has a rich history of innovation and was pivotal to the development of the semiconductor manufacturing process in the 1970s and 80s with the introduction of its fluoro-polymer filter. We sit down with president, Takuya Iwata, to learn more about Iwata and its current five business divisions, and how this company has been nestled deep in the heart of Japanese industry for over a century.
Established in 1902, Iwata & Co., Ltd.’s main business is the manufacture and provision of an extensive range of chemicals to a wide variety of industries. The company has a rich history of innovation and was pivotal to the development of the semiconductor manufacturing process in the 1970s and 80s with the introduction of its fluoro-polymer filter. We sit down with president, Takuya Iwata, to learn more about Iwata and its current five business divisions, and how this company has been nestled deep in the heart of Japanese industry for over a century.
As the world races to lower carbon emissions in line with the goals of the Paris Climate Agreement, it is essential for power and manufacturing plant owners to adopt the latest technologies, parts and equipment in a bid to reduce the environmental impact of their operations. And Seo Koatsu Kogyo (SKK) – a Japanese firm which manufactures steel-forged products, heat exchangers and other heavy industry products – is supporting its customers in the energy and manufacturing industries in this endeavor.
As the world races to lower carbon emissions in line with the goals of the Paris Climate Agreement, it is essential for power and manufacturing plant owners to adopt the latest technologies, parts and equipment in a bid to reduce the environmental impact of their operations. And Seo Koatsu Kogyo (SKK) – a Japanese firm which manufactures steel-forged products, heat exchangers and other heavy industry products – is supporting its customers in the energy and manufacturing industries in this endeavor.
Using the finest technologies, Alps Pharmaceutical Co., Ltd. extracts only the active ingredients from plants and herbs to develop high-quality pharmaceutical, food and cosmetic products.
Using the finest technologies, Alps Pharmaceutical Co., Ltd. extracts only the active ingredients from plants and herbs to develop high-quality pharmaceutical, food and cosmetic products.
Japanese firm CellSource is an innovative new healthcare service provider pioneering the industrialization of regenerative medicine, one of the groundbreaking new fields in the global medical industry.
Japanese firm CellSource is an innovative new healthcare service provider pioneering the industrialization of regenerative medicine, one of the groundbreaking new fields in the global medical industry.
Japanese innovation will be at the core of fourth industrial revolution technologies such as robotics and AI, as well as a new era of healthcare defined by regenerative medicine, next-generation pharmaceuticals and health supplements.
Japanese innovation will be at the core of fourth industrial revolution technologies such as robotics and AI, as well as a new era of healthcare defined by regenerative medicine, next-generation pharmaceuticals and health supplements.
The fast-growing Japanese drone maker has developed its own autonomous flight control and SLAM technologies that allow its drones to be used in places beyond the reaches of GPS/GNSS-based competitors.
The fast-growing Japanese drone maker has developed its own autonomous flight control and SLAM technologies that allow its drones to be used in places beyond the reaches of GPS/GNSS-based competitors.
The fast-growing Japanese drone maker has developed its own autonomous flight control and SLAM technologies that allow its drones to be used in places beyond the reaches of GPS/GNSS-based competitors. We speak to COO, Satoshi Washiya, about how far the company has come in its five-year history, some of its latest high-end-level drones, and its international strategy moving forward.
The fast-growing Japanese drone maker has developed its own autonomous flight control and SLAM technologies that allow its drones to be used in places beyond the reaches of GPS/GNSS-based competitors. We speak to COO, Satoshi Washiya, about how far the company has come in its five-year history, some of its latest high-end-level drones, and its international strategy moving forward.
Regenerative medicine is set to revolutionize the medical industry over the coming years, offering treatments for once incurable conditions including cancer, Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, spinal cord injuries, among others. We speak with Masato Tsumamoto, president of CellSource, who offers his insight into the potential of regenerative medicine and how his company has positioned itself at the forefront of this exciting new field of healthcare.
Regenerative medicine is set to revolutionize the medical industry over the coming years, offering treatments for once incurable conditions including cancer, Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, spinal cord injuries, among others. We speak with Masato Tsumamoto, president of CellSource, who offers his insight into the potential of regenerative medicine and how his company has positioned itself at the forefront of this exciting new field of healthcare.
Established in 1947, Alps Pharmaceutical Ind. Co., Ltd. combines its expertise in traditional medicine and prowess in modern science and innovation to turn nature’s bounty into a vast range of pharmaceutical, food and cosmetic products and ingredients. The Worldfolio sits down with president, Mr. Osamu Ushimaru, to discuss some of the company’s latest developments, such as its work in Eubioflavonoids, which have the potential to have an enormous impact on healthcare. Mr. Ushimaru also discusses how Alps’ “power of assembling technology” sets it apart from its competitors, while also giving some insight into the company’s rich history of R&D and innovation.
Established in 1947, Alps Pharmaceutical Ind. Co., Ltd. combines its expertise in traditional medicine and prowess in modern science and innovation to turn nature’s bounty into a vast range of pharmaceutical, food and cosmetic products and ingredients. The Worldfolio sits down with president, Mr. Osamu Ushimaru, to discuss some of the company’s latest developments, such as its work in Eubioflavonoids, which have the potential to have an enormous impact on healthcare. Mr. Ushimaru also discusses how Alps’ “power of assembling technology” sets it apart from its competitors, while also giving some insight into the company’s rich history of R&D and innovation.
One of Japan’s leading health supplements original equipment manufacturers (OEMs), API’s fully integrated production system covers every process, from the procurement of high-quality ingredients to the manufacturing of the finished products. In this interview, president, Takahiko Nonogaki, discusses the company’s history, gives his insight into the health supplements industry and explains how API plans to leverage on new technologies like AI to develop better products as it looks to expand in the international market.
One of Japan’s leading health supplements original equipment manufacturers (OEMs), API’s fully integrated production system covers every process, from the procurement of high-quality ingredients to the manufacturing of the finished products. In this interview, president, Takahiko Nonogaki, discusses the company’s history, gives his insight into the health supplements industry and explains how API plans to leverage on new technologies like AI to develop better products as it looks to expand in the international market.
